<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:g-core="http://base.google.com/ns/1.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel rdf:about="http://www.practicaldiabetes.com">
    <title>Practical Diabetes International news RSS Feed</title>
    <link>http://www.practicaldiabetes.com</link>
    <description>Practical Diabetes International news RSS Feed</description>
    <items>
      <rdf:Seq>
        <rdf:li resource="http://www.practicaldiabetes.com/details/news/1444521/Reduced_renal_events_with_a_gliclazide.html" />
        <rdf:li resource="http://www.practicaldiabetes.com/details/news/1444513/Insulin_analogue_improves_glucose_control.html" />
        <rdf:li resource="http://www.practicaldiabetes.com/details/news/1444511/One-year_study_shows_benefit_of_CGM.html" />
        <rdf:li resource="http://www.practicaldiabetes.com/details/news/1444501/CV_events_in_sitagliptin_vs_sulphonylurea.html" />
        <rdf:li resource="http://www.practicaldiabetes.com/details/news/1390581/New_type_1_diabetes_genes_unravelled.html" />
      </rdf:Seq>
    </items>
  </channel>
  <item rdf:about="http://www.practicaldiabetes.com/details/news/1444521/Reduced_renal_events_with_a_gliclazide.html">
    <title>Reduced renal events with a gliclazide</title>
    <link>http://www.practicaldiabetes.com/details/news/1444521/Reduced_renal_events_with_a_gliclazide.html</link>
    <description>Treatment with an intensive glucose control regimen based on modified-release gliclazide reduces major renal events, according to new results from the ADVANCE trial.</description>
    <dc:date>2012-01-19T15:43:00Z</dc:date>
  </item>
  <item rdf:about="http://www.practicaldiabetes.com/details/news/1444513/Insulin_analogue_improves_glucose_control.html">
    <title>Insulin analogue improves glucose control</title>
    <link>http://www.practicaldiabetes.com/details/news/1444513/Insulin_analogue_improves_glucose_control.html</link>
    <description>Patients with type 2 diabetes starting on insulin analogue treatment showed improved glucose control and low rates of hypoglycaemia, according to results from the A1chieve study.</description>
    <dc:date>2012-01-19T15:42:00Z</dc:date>
  </item>
  <item rdf:about="http://www.practicaldiabetes.com/details/news/1444511/One-year_study_shows_benefit_of_CGM.html">
    <title>One-year study shows benefit of CGM</title>
    <link>http://www.practicaldiabetes.com/details/news/1444511/One-year_study_shows_benefit_of_CGM.html</link>
    <description>Continuous glucose monitoring enables patients with poorly controlled type 1 diabetes to achieve sustained reductions in HbA1c that average 0.5% lower than usual self-monitoring, according to results from a one-year study.</description>
    <dc:date>2012-01-19T15:38:00Z</dc:date>
  </item>
  <item rdf:about="http://www.practicaldiabetes.com/details/news/1444501/CV_events_in_sitagliptin_vs_sulphonylurea.html">
    <title>CV events in sitagliptin vs sulphonylurea</title>
    <link>http://www.practicaldiabetes.com/details/news/1444501/CV_events_in_sitagliptin_vs_sulphonylurea.html</link>
    <description>The incidence of cardiovascular events in patients with type 2 diabetes treated with the DPP-4 inhibitor sitagliptin is significantly lower than in those treated with sulphonylureas, according to a pooled analysis.</description>
    <dc:date>2012-01-19T15:28:00Z</dc:date>
  </item>
  <item rdf:about="http://www.practicaldiabetes.com/details/news/1390581/New_type_1_diabetes_genes_unravelled.html">
    <title>New type 1 diabetes genes unravelled</title>
    <link>http://www.practicaldiabetes.com/details/news/1390581/New_type_1_diabetes_genes_unravelled.html</link>
    <description>Researchers from the Children&amp;rsquo;s Hospital of Philadelphia have identified a new group of genetic differences that may increase the risk of developing type 1 diabetes.</description>
    <dc:date>2011-11-07T10:08:00Z</dc:date>
  </item>
</rdf:RDF>


